Ethical Issues Concerning the Relationship between Medical Students/Residents and the Pharmaceutical Industry (의대생/전공의와 제약회사의 윤리적 관계)

Cheong Yooseok (정유석); PARK JAE HYUN (박재현); KOH YS (고윤석)

doi:10.35301/ksme.2011.14.2.215

Ethical Issues Concerning the Relationship between Medical Students/Residents and the Pharmaceutical Industry

Korean Journal of Medical Ethics
Abbr : 의료윤리
2011, 14(2), pp.215-223
DOI : 10.35301/ksme.2011.14.2.215
Publisher : The Korean Society For Medical Ethics
Research Area : Medicine and Pharmacy > General Medicine
Published : June 30, 2011

Cheong Yooseok ¹, PARK JAE HYUN ², KOH YS ³

¹단국대학교
²경희대학교
³울산대학교

Accredited

ABSTRACT

The pharmaceutical industry interacts with the medical profession by supporting clinical research and assisting in medical education activities in academic medical centers. Medical students and residents spend years establishing patterns of prescribing and making relationships with pharmaceutical companies. The pharmaceutical industry has a significant presence during residency training, gaining the overall acceptance of trainees, and appears to influence prescribing behavior. Contact with pharmaceutical representatives is common among medical students and residents. Residents acknowledge the potential for industry influence in others, but generally not in themselves, despite evidence that they themselves are influenced as well. The prescriptions written by residents are associated with pharmaceutical representative visits and the availability of samples. A variety of policy and educational guidelines appear to influence residents’ attitudes toward interactions with industry representatives, although data on the long-term effects of these interventions are limited. This article contends that medical training programs can benefit from policies and curricula that teach medical students and residents about the influence of marketing and how to critically evaluate the information they receive from industry representatives.

KEYWORDS

medical students, residents, physician-pharmaceutical interaction, conflict of interest

Citation status

* References for papers published after 2023 are currently being built.

[journal] Adler, L / 1999 / The pharmaceutical industry’s influence on chief medical residents / JGIM 14(2) : 128~

[book] Bernard L / 2005 / Resolving ethical dilemmas / Willams & Wilkins : 209~212

[journal] Boltri JM / 2002 / Effect of antihypertensive samples on physician prescribing patterns / Fam Med 34 : 729~731

[journal] Brotzman GL / 1993 / The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities / J Gen Intern Med 8 : 130~134

[journal] Chren MM / 1994 / Physicians’behavior and their interactions with drug companies: a controlled study of physicians who requested additions to a hospital drug formulary / JAMA 271 : 684~689

[web] / Code on Interactions with Healthcare Professionals PhRMA 2008 / http://www.news.pharma-mkting.com/pmn77-article01.htm

[journal] Ferguson RP / 1999 / Encounters with pharmaceutical sales representatives among practicing internists / Am J Med 107 : 149~152

[journal] Hodges B / 1995 / Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks / Can Med Assoc J 153 : 553~559

[report] House of Commons Health Committee / 2005 / The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004-05 : 1~126

[web] / http;//amsascorecard.org/ / http;//amsascorecard.org/

[web] Institute of Medicine / Conflict of Interest in Medical Research, Education, and Practice / The National Academies Press / http://www.nap.edu/catalog/12598.html

[journal] Keim SM / 2004 / Interactions between emergency medicine programs and the pharmaceutical industry / Acad Emerg Med 11 : 19~26

[journal] Lichstein PR / 1992 / Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors / Arch Intern Med 152 : 1009~1013

[journal] Lurie N / 1990 / Pharmaceutical representatives in academic medical centers: interaction with faculty and house staff / JGIM 5 : 240~243

[journal] McCormick BB / 2001 / Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior / JAMA 286 : 1994~1999

[journal] Montague BT / 2008 / A systematic review of curricula on relationships between residents and the pharmaceutical industry / Med Educ 42 : 301~308

[journal] Orlowski JP / 1992 / The effects of pharmaceutical firm enticements on physician prescribing patterns: there’’s no such thing as a free lunch / Chest 102 : 270~273

[journal] Oxman AD / 1995 / No magic bullets: a systematic review of 102 trials of interventions to improve professional practice / Can Med Assoc J 153 : 1423~1431

[web] PhRMA / Code of Interactions with healthcare professionals / http://www.phrma.org/about/principles-guidelines /code-interactions-healthcare-professionals

[journal] Randall ML / 2005 / Attitudes and behaviours of psychiatry residents toward pharmaceutical representatives before and after an educational intervention / Acad Psychiatry 29(1) : 33~39

[journal] Schneider JA / 2006 / Residents perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention / Acad Med 81(7) : 595~602

[journal] Schwartz TL / 2001 / Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits / Ann Clin Psychiatry 13 : 159~162

[journal] Sergeant MD / 1996 / Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario / Can Med Assoc J 155 : 1243~1248

[journal] Sierles / 2005 / Medical students’exposure to and attitudes about drug company interactions: a national survey / JAMA 294 : 1034~1042

[journal] Steinman MA / 2001 / Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions / Am J Med 110 : 551~557

[journal] Tattersal M / 2006 / Doctors behaving badly / Med J Aust 185 : 299~300

[journal] Varley CK / 2005 / Benjamin S: A survey of the interactions between psychiatry residency programs and the pharmaceutical / Acad Psychiatry 29 : 40~46

[journal] Wazana A / 2004 / Using the literature in developing McGills guidelines for interactions between residents and the pharmaceutical industry / Acad Med 79 : 1033~1040

[journal] Ziegler MG / 1995 / The accuracy of drug information from pharmaceutical sales representatives / JAMA 273 : 1296~1298

KJCKorea
Journal Central

Korean Journal of Medical Ethics 2023 KCI Impact Factor : 1.21

Ethical Issues Concerning the Relationship between Medical Students/Residents and the Pharmaceutical Industry

ABSTRACT

KEYWORDS

Citation status

* References for papers published after 2023 are currently being built.

Korean Journal of Medical Ethics 2023 KCI Impact Factor : 1.21

Ethical Issues Concerning the Relationship between Medical Students/Residents and the Pharmaceutical Industry

ABSTRACT

KEYWORDS

Statistics

Tools

Issue List

Citation status

KCI Citation Counts (2)

REFERENCES (29) * References for papers published after 2023 are currently being built.

Search PDF

Citation

* References for papers published after 2023 are currently being built.